Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.670
-0.140 (-3.67%)
Aug 14, 2025, 2:32 PM - Market open

Prime Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
4813738171,609--
Upgrade
Market Cap Growth
-46.88%-54.41%-49.22%---
Upgrade
Enterprise Value
5002386691,890--
Upgrade
Last Close Price
3.812.928.8618.58--
Upgrade
PS Ratio
97.46124.90----
Upgrade
PB Ratio
8.202.436.145.09--
Upgrade
P/TBV Ratio
7.932.436.145.09--
Upgrade
EV/Sales Ratio
100.8779.89----
Upgrade
Debt / Equity Ratio
1.970.270.100.090.040.52
Upgrade
Asset Turnover
0.020.01---0.16
Upgrade
Quick Ratio
2.995.022.1611.004.652.74
Upgrade
Current Ratio
3.565.582.5311.104.672.75
Upgrade
Return on Equity (ROE)
-154.81%-136.88%-88.19%-43.83%-121.13%-19.56%
Upgrade
Return on Assets (ROA)
-47.39%-51.51%-43.15%-22.00%-29.61%-1.84%
Upgrade
Return on Capital (ROIC)
-60.96%-74.30%-48.63%-24.48%-35.09%-2.22%
Upgrade
Earnings Yield
-41.30%-52.58%-24.25%-7.57%--
Upgrade
FCF Yield
-22.18%-34.94%-21.31%-9.19%--
Upgrade
Buyback Yield / Dilution
-24.42%-30.37%-168.41%-161.23%-391.47%-77.53%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q